APA (7th ed.) Citation

F, L., N, K., A, K., M, S., S, Z., N, G., . . . I, Z. (2018). Validation of α-Synuclein as a CSF Biomarker for Sporadic Creutzfeldt-Jakob Disease. Molecular neurobiology, 55(3), 2249. https://doi.org/10.1007/s12035-017-0479-5

Chicago Style (17th ed.) Citation

F, Llorens, et al. "Validation of α-Synuclein as a CSF Biomarker for Sporadic Creutzfeldt-Jakob Disease." Molecular Neurobiology 55, no. 3 (2018): 2249. https://doi.org/10.1007/s12035-017-0479-5.

MLA (9th ed.) Citation

F, Llorens, et al. "Validation of α-Synuclein as a CSF Biomarker for Sporadic Creutzfeldt-Jakob Disease." Molecular Neurobiology, vol. 55, no. 3, 2018, p. 2249, https://doi.org/10.1007/s12035-017-0479-5.